SCHEMBL7752218

SCHEMBL7752218

CCC(S)(CC)CC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 1/20 0.43
CHRM1 P11229 1/20 0.43
TBXA2R P21731 1/20 0.43
ADRA1A P35348 1/20 0.43
CYP2C19 P33261 2/20 0.42
HIF1A Q16665 2/20 0.42
CYP2D6 P10635 1/20 0.42
TSHR P16473 1/20 0.42
FFAR3 O14843 2/20 0.40
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.37
FFAR1 O14842 1/20 0.37
CPT2 P23786 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10580990 0.94 HMGCR (0.43) HMGCRCHRM1TBXA2RADRA1ACYP2C19
SCHEMBL10581603 0.84 KMT2A (0.45) TSHRFFAR3ALDH1A1FFAR1TDP1
SCHEMBL2393344 0.79 TDP1 (0.45) TSHRALDH1A1FFAR1CPT2TDP1
SCHEMBL25337653 0.76
SCHEMBL5830062 0.75 TDP1 (0.41) TSHRALDH1A1FFAR1CPT2TDP1
SCHEMBL11211995 0.74 CYP2D6 (0.44) HMGCRCHRM1TBXA2RADRA1ACYP2C19
T-Butylacetic Acid SCHEMBL31223224 0.74 HMGCR (0.46) HMGCRCHRM1TBXA2RADRA1ACYP2C19
SCHEMBL869890 0.74 HMGCR (0.46) HMGCRCHRM1TBXA2RADRA1ACYP2C19
SCHEMBL10579205 0.74 KMT2A (0.50) TSHRFFAR3ALDH1A1FFAR1TDP1
SCHEMBL869582 0.74 HMGCR (0.46) HMGCRCHRM1TBXA2RADRA1ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001036006-A1 OPIOID METALLOPEPTIDE COMPOSITIONS AND METHODS PALATIN TECHNOLOGIES, INC. (US) 2001-05-25 WO disclosed
EP-0219275-A3 VASOPRESSIN COMPOUNDS SMITHKLINE BECKMAN CORPORATION (US) 1989-05-03 EP disclosed
US-4749782-A TREATING CONGESTIVE HEART FAILURE, HYPERTENSION SMITHKLINE BECKMAN CORPORATION (US) 1988-06-07 US disclosed
US-4749782-A TREATING CONGESTIVE HEART FAILURE, HYPERTENSION SMITHKLINE BECKMAN CORPORATION (US) 1988-06-07 US disclosed
EP-0219275-A2 Vasopressin compounds SMITHKLINE BECKMAN CORPORATION (US) 1987-04-22 EP disclosed
EP-0219275-A2 Vasopressin compounds SMITHKLINE BECKMAN CORPORATION (US) 1987-04-22 EP disclosed